SCHEMBL5705804

SCHEMBL5705804

CC(OCCN)c1nc2c([nH]1)-c1ccccc1Sc1ccccc1-2

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.35
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4692954 0.86 BCHE (0.36) KDM4EALDH1A1
SCHEMBL4694471 0.84 CYP1A2 (0.34) KDM4EALDH1A1
SCHEMBL4694104 0.68 SIGMAR1 (0.33)
SCHEMBL4696483 0.68 BCHE (0.31)
SCHEMBL4695663 0.67 CHRM2 (0.35) NPY5RKDM4EALDH1A1
SCHEMBL4695791 0.67
SCHEMBL4693296 0.65 CYP1A2 (0.35) KDM4EALDH1A1
SCHEMBL6231367 0.63 NPY5R (0.40) NPY5RKDM4EALDH1A1
SCHEMBL5234902 0.62 PDE5A (0.42) KDM4E
Napazimone SCHEMBL30092410 0.59 KDM4E (0.54) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1684749-A1 USE OF 1,3-DIAZA-DIBENZO[e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS PLIVA-ISTRAZIVACKI INSTITUT d.o.o. (HR) 2006-08-02 EP claimed
WO-2005049016-A1 USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2005-06-02 WO claimed